ANAGENICS LIMITED - Announcements

0.00%

0.5¢

Market Cap $2.481M

Consumer Defensive Household & Personal Products

Anagenics Limited is an Australia-based health and beauty-tech company that operates... Anagenics Limited is an Australia-based health and beauty-tech company that operates health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. The Company operates through its holding entity, Anagenics Limited and its main operating subsidiary company BLC Cosmetics Pty Limited (BLC) being a distributor of prestige beauty cosmetics and beauty equipment. BLC is an importer and distributor of prestige international and local skin care and wellbeing brands, namely Thalgo, Comfort Zone, Priori and other premium brands. BLC services over 1,000 spas, clinics, salons, retail stores and online in Australia, New Zealand and the Pacific Islands. The Company's brands consist of evolis and Uspa. Evolis is an anti-ageing hair care collection focused on harnessing the scientific research to give customers' thicker and healthier hair.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AN1	Appendix 2A and Cleansing Notice		14/04/20	338.67KB	Share
AN1	Proposed issue of Securities - CDY		08/04/20	26.83KB	Share
AN1	Reinstatement to Official Quotation	PRICE SENSITIVE	07/04/20	70.86KB	Share
AN1	Proposed issue of Securities - CDY		07/04/20	28.78KB	Share
AN1	Cellmid Share Placement Raises $6 Million	PRICE SENSITIVE	07/04/20	72.27KB	Share
AN1	Response to ASX Query Letter	PRICE SENSITIVE	06/04/20	662.92KB	Share
AN1	Suspension from Official Quotation	PRICE SENSITIVE	06/04/20	177.04KB	Share
AN1	Trading Halt	PRICE SENSITIVE	02/04/20	172.74KB	Share
AN1	Reinstatement to Official Quotation	PRICE SENSITIVE	27/03/20	71.03KB	Share
AN1	Market Update on COVID-19	PRICE SENSITIVE	27/03/20	69.7KB	Share
AN1	Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement	PRICE SENSITIVE	27/03/20	86.33KB	Share
AN1	Suspension from Official Quotation	PRICE SENSITIVE	24/03/20	178.81KB	Share
AN1	Trading Halt	PRICE SENSITIVE	20/03/20	173.63KB	Share
AN1	Appendix 3G		04/03/20	278.07KB	Share
AN1	Appendix 4D, Half Year Accounts and Presentation	PRICE SENSITIVE	26/02/20	3.06MB	Share
AN1	Cellmid's Evolis Patent to be Granted in China	PRICE SENSITIVE	04/02/20	70.43KB	Share
AN1	Appendix 4C and Notes to Appendix 4C	PRICE SENSITIVE	30/01/20	236.85KB	Share
AN1	Key Midkine Antibody Patents Granted in the US and Europe	PRICE SENSITIVE	06/01/20	89.81KB	Share
AN1	Cellmid Reports on QVC Sales	PRICE SENSITIVE	05/12/19	93.27KB	Share
AN1	Change in substantial holding		22/11/19	863.77KB	Share
AN1	Change of Director's Interest Notice - Eck		22/11/19	259.43KB	Share
AN1	Change of Director's Interest Notice - Halasz		22/11/19	262.29KB	Share
AN1	Appendix 3B and Cleansing Notice		20/11/19	462.3KB	Share
AN1	Results of Annual General Meeting		19/11/19	97.95KB	Share
AN1	AGM Presentation to Shareholders		19/11/19	2.72MB	Share
AN1	Change of Director's Interest Notice - Cross		12/11/19	158.84KB	Share
AN1	Change of Director's Interest Notice - King		12/11/19	159.4KB	Share
AN1	Change of Director's Interest Notice - Gordon		12/11/19	158.5KB	Share
AN1	Appendix 3B and Cleansing Notice		08/11/19	470.68KB	Share
AN1	Cellmid Signs Trading Agreement With API/Priceline	PRICE SENSITIVE	06/11/19	95.47KB	Share
AN1	Cellmid Share Purchase Plan Completed		06/11/19	77.53KB	Share
AN1	Cellmid Appoints CEO to Advangen USA to Expand Distribution		31/10/19	82.69KB	Share
AN1	Supplementary Information on AGM Resolutions		24/10/19	88.59KB	Share
AN1	Appendix 4C and Notes to Appendix 4C	PRICE SENSITIVE	23/10/19	248.37KB	Share
AN1	Notice of Annual General Meeting/Proxy Form		18/10/19	1.4MB	Share
AN1	Appendix 3B and Cleansing Notice		18/10/19	474.98KB	Share
AN1	SPP Offer Booklet		15/10/19	214.57KB	Share
AN1	Cleansing notice		15/10/19	78.94KB	Share
AN1	New TV Shopping Agreement for Evolis	PRICE SENSITIVE	14/10/19	89.05KB	Share
AN1	Cellmid Share Placement raises $1.5 million	PRICE SENSITIVE	14/10/19	72.41KB	Share
AN1	Trading Halt	PRICE SENSITIVE	10/10/19	130.36KB	Share
AN1	New Evolis Distribution & Supply Agreements - China & Europe	PRICE SENSITIVE	01/10/19	103.59KB	Share
AN1	Cellmid receives R&D tax credit		27/09/19	60.35KB	Share
AN1	Appendix 4G and Corporate Governance Statement		16/09/19	366.53KB	Share
AN1	Annual Report to shareholders		16/09/19	2.14MB	Share
AN1	FY19 Results Presentation		28/08/19	3.16MB	Share
AN1	FY2019 Financial Results	PRICE SENSITIVE	28/08/19	74.43KB	Share
AN1	Appendix 4E and FY19 Financial Report	PRICE SENSITIVE	28/08/19	2.1MB	Share
AN1	Patent for Improved Midkine Antibody Allowed in Europe	PRICE SENSITIVE	22/08/19	78.33KB	Share
AN1	CDY Signs Distribution Agreement for EVOLIS in South Korea	PRICE SENSITIVE	06/08/19	102.3KB	Share
AN1	Response to Appendix 4C Query	PRICE SENSITIVE	01/08/19	413.12KB	Share
AN1	Appendix 3B		30/07/19	383.94KB	Share
AN1	Appendix 4C and Notes to Appendix 4C	PRICE SENSITIVE	26/07/19	279.33KB	Share
AN1	Cellmid Investor Newsletter		10/07/19	421.83KB	Share
AN1	Response to ASX Aware Query	PRICE SENSITIVE	08/07/19	434.23KB	Share
AN1	Cellmid Sets Another Sales Record in Q4 FY2019	PRICE SENSITIVE	04/07/19	93.84KB	Share
AN1	Change of Director's Interest Notice - Halasz		07/06/19	546.79KB	Share
AN1	FY2020 Growth Strategy Update		28/05/19	1.51MB	Share
AN1	Cellmid appoints new Lyramid CEO		28/05/19	207KB	Share
AN1	Minimum Holding Buy-Back Complete - ASIC Form 484		23/05/19	277.28KB	Share
AN1	Minimum Holding Buy-Back Closed		21/05/19	275.36KB	Share
AN1	Change of Director's Interest Notice - Maria Halasz		06/05/19	546.83KB	Share
AN1	Cellmid's Evolis Registered in European Union (EU)	PRICE SENSITIVE	30/04/19	297.58KB	Share
AN1	Appendix 4C and Notes to Appendix 4C	PRICE SENSITIVE	29/04/19	739KB	Share
AN1	Change of Director's Interest Notice - Halasz		18/04/19	737.91KB	Share
AN1	Cellmid Alopecia Patent Allowed in Eurpoe		02/04/19	245.17KB	Share
AN1	Cellmid Investor Newsletter		26/03/19	229.87KB	Share
AN1	Minimum Holding Share Buy-Back	PRICE SENSITIVE	19/03/19	254.77KB	Share
AN1	Appendix 4D, Half Year Accounts and Strategy Update	PRICE SENSITIVE	21/02/19	2.1MB	Share
AN1	Significant New Findings Published on Midkine	PRICE SENSITIVE	07/02/19	268.65KB	Share
AN1	Appendix 4C and Notes to Appendix 4C	PRICE SENSITIVE	23/01/19	549.1KB	Share
AN1	Cellmid Expects Record Sales in Q2 FY2019	PRICE SENSITIVE	12/12/18	222.34KB	Share
AN1	Cellmid Appoints Exclusive New Zealand Distributor	PRICE SENSITIVE	19/11/18	223.09KB	Share
AN1	Change of Director's Interest Notice - Halasz		13/11/18	356.45KB	Share
AN1	Change of Director's Interest Notice - Eck		13/11/18	350.32KB	Share
AN1	Appendix 3B and Cleansing Notice		12/11/18	898.77KB	Share
AN1	Results of Annual General Meeting		08/11/18	408.92KB	Share
AN1	AGM Presentation to Shareholders		08/11/18	1.85MB	Share
AN1	New Patents for Midkine Antibodies in USA and Europe	PRICE SENSITIVE	07/11/18	226.65KB	Share
AN1	Ikon Legal Action - Decision	PRICE SENSITIVE	02/11/18	199.86KB	Share
AN1	Trading Halt	PRICE SENSITIVE	02/11/18	144.58KB	Share
AN1	Cellmid's Evolis Successfully Launched in USA stores	PRICE SENSITIVE	01/11/18	227.68KB	Share
AN1	Repayment of R&D Loan	PRICE SENSITIVE	01/11/18	206.24KB	Share
AN1	Investor Presentation	PRICE SENSITIVE	31/10/18	2.36MB	Share
AN1	Cellmid receives R&D tax credit		30/10/18	62.71KB	Share
AN1	Appendix 4C and Notes to Appendix 4C	PRICE SENSITIVE	15/10/18	479.22KB	Share
AN1	Notice of Annual General Meeting/Proxy Form		09/10/18	1.25MB	Share
AN1	Appendix 3B and Cleansing Notice		08/10/18	887.46KB	Share
AN1	Cleansing Notice		03/10/18	196.69KB	Share
AN1	Appendix 3B		03/10/18	860KB	Share
AN1	Appendix 3B		28/09/18	875.43KB	Share
AN1	Change of Registry Address: Automic P/L - Sydney Office		28/09/18	91.41KB	Share
AN1	Appendix 4G and Corporate Governance Statement		27/09/18	525.71KB	Share
AN1	Annual Report to shareholders		27/09/18	2.27MB	Share
AN1	Change of Director's Interest Notice - Gordon		25/09/18	253.85KB	Share
AN1	Clarification Announcement		24/09/18	80.29KB	Share
AN1	CDY Investor Newsletter - 21 September 2018		21/09/18	526.81KB	Share
AN1	Date of Annual General Meeting		19/09/18	68.96KB	Share
AN1	Full Year Statutory Accounts		19/09/18	423.06KB	Share
AN1	Becoming a substantial holder		14/09/18	185.59KB	Share

AN1 Appendix 2A and Cleansing Notice
14/04/20		338.67KB	Share
AN1 Proposed issue of Securities - CDY
08/04/20		26.83KB	Share
AN1 Reinstatement to Official Quotation
07/04/20	PRICE SENSITIVE	70.86KB	Share
AN1 Proposed issue of Securities - CDY
07/04/20		28.78KB	Share
AN1 Cellmid Share Placement Raises $6 Million
07/04/20	PRICE SENSITIVE	72.27KB	Share
AN1 Response to ASX Query Letter
06/04/20	PRICE SENSITIVE	662.92KB	Share
AN1 Suspension from Official Quotation
06/04/20	PRICE SENSITIVE	177.04KB	Share
AN1 Trading Halt
02/04/20	PRICE SENSITIVE	172.74KB	Share
AN1 Reinstatement to Official Quotation
27/03/20	PRICE SENSITIVE	71.03KB	Share
AN1 Market Update on COVID-19
27/03/20	PRICE SENSITIVE	69.7KB	Share
AN1 Cellmid Signs COVID-19 Rapid Diagnostic Supply Agreement
27/03/20	PRICE SENSITIVE	86.33KB	Share
AN1 Suspension from Official Quotation
24/03/20	PRICE SENSITIVE	178.81KB	Share
AN1 Trading Halt
20/03/20	PRICE SENSITIVE	173.63KB	Share
AN1 Appendix 3G
04/03/20		278.07KB	Share
AN1 Appendix 4D, Half Year Accounts and Presentation
26/02/20	PRICE SENSITIVE	3.06MB	Share
AN1 Cellmid's Evolis Patent to be Granted in China
04/02/20	PRICE SENSITIVE	70.43KB	Share
AN1 Appendix 4C and Notes to Appendix 4C
30/01/20	PRICE SENSITIVE	236.85KB	Share
AN1 Key Midkine Antibody Patents Granted in the US and Europe
06/01/20	PRICE SENSITIVE	89.81KB	Share
AN1 Cellmid Reports on QVC Sales
05/12/19	PRICE SENSITIVE	93.27KB	Share
AN1 Change in substantial holding
22/11/19		863.77KB	Share
AN1 Change of Director's Interest Notice - Eck
22/11/19		259.43KB	Share
AN1 Change of Director's Interest Notice - Halasz
22/11/19		262.29KB	Share
AN1 Appendix 3B and Cleansing Notice
20/11/19		462.3KB	Share
AN1 Results of Annual General Meeting
19/11/19		97.95KB	Share
AN1 AGM Presentation to Shareholders
19/11/19		2.72MB	Share
AN1 Change of Director's Interest Notice - Cross
12/11/19		158.84KB	Share
AN1 Change of Director's Interest Notice - King
12/11/19		159.4KB	Share
AN1 Change of Director's Interest Notice - Gordon
12/11/19		158.5KB	Share
AN1 Appendix 3B and Cleansing Notice
08/11/19		470.68KB	Share
AN1 Cellmid Signs Trading Agreement With API/Priceline
06/11/19	PRICE SENSITIVE	95.47KB	Share
AN1 Cellmid Share Purchase Plan Completed
06/11/19		77.53KB	Share
AN1 Cellmid Appoints CEO to Advangen USA to Expand Distribution
31/10/19		82.69KB	Share
AN1 Supplementary Information on AGM Resolutions
24/10/19		88.59KB	Share
AN1 Appendix 4C and Notes to Appendix 4C
23/10/19	PRICE SENSITIVE	248.37KB	Share
AN1 Notice of Annual General Meeting/Proxy Form
18/10/19		1.4MB	Share
AN1 Appendix 3B and Cleansing Notice
18/10/19		474.98KB	Share
AN1 SPP Offer Booklet
15/10/19		214.57KB	Share
AN1 Cleansing notice
15/10/19		78.94KB	Share
AN1 New TV Shopping Agreement for Evolis
14/10/19	PRICE SENSITIVE	89.05KB	Share
AN1 Cellmid Share Placement raises $1.5 million
14/10/19	PRICE SENSITIVE	72.41KB	Share
AN1 Trading Halt
10/10/19	PRICE SENSITIVE	130.36KB	Share
AN1 New Evolis Distribution & Supply Agreements - China & Europe
01/10/19	PRICE SENSITIVE	103.59KB	Share
AN1 Cellmid receives R&D tax credit
27/09/19		60.35KB	Share
AN1 Appendix 4G and Corporate Governance Statement
16/09/19		366.53KB	Share
AN1 Annual Report to shareholders
16/09/19		2.14MB	Share
AN1 FY19 Results Presentation
28/08/19		3.16MB	Share
AN1 FY2019 Financial Results
28/08/19	PRICE SENSITIVE	74.43KB	Share
AN1 Appendix 4E and FY19 Financial Report
28/08/19	PRICE SENSITIVE	2.1MB	Share
AN1 Patent for Improved Midkine Antibody Allowed in Europe
22/08/19	PRICE SENSITIVE	78.33KB	Share
AN1 CDY Signs Distribution Agreement for EVOLIS in South Korea
06/08/19	PRICE SENSITIVE	102.3KB	Share
AN1 Response to Appendix 4C Query
01/08/19	PRICE SENSITIVE	413.12KB	Share
AN1 Appendix 3B
30/07/19		383.94KB	Share
AN1 Appendix 4C and Notes to Appendix 4C
26/07/19	PRICE SENSITIVE	279.33KB	Share
AN1 Cellmid Investor Newsletter
10/07/19		421.83KB	Share
AN1 Response to ASX Aware Query
08/07/19	PRICE SENSITIVE	434.23KB	Share
AN1 Cellmid Sets Another Sales Record in Q4 FY2019
04/07/19	PRICE SENSITIVE	93.84KB	Share
AN1 Change of Director's Interest Notice - Halasz
07/06/19		546.79KB	Share
AN1 FY2020 Growth Strategy Update
28/05/19		1.51MB	Share
AN1 Cellmid appoints new Lyramid CEO
28/05/19		207KB	Share
AN1 Minimum Holding Buy-Back Complete - ASIC Form 484
23/05/19		277.28KB	Share
AN1 Minimum Holding Buy-Back Closed
21/05/19		275.36KB	Share
AN1 Change of Director's Interest Notice - Maria Halasz
06/05/19		546.83KB	Share
AN1 Cellmid's Evolis Registered in European Union (EU)
30/04/19	PRICE SENSITIVE	297.58KB	Share
AN1 Appendix 4C and Notes to Appendix 4C
29/04/19	PRICE SENSITIVE	739KB	Share
AN1 Change of Director's Interest Notice - Halasz
18/04/19		737.91KB	Share
AN1 Cellmid Alopecia Patent Allowed in Eurpoe
02/04/19		245.17KB	Share
AN1 Cellmid Investor Newsletter
26/03/19		229.87KB	Share
AN1 Minimum Holding Share Buy-Back
19/03/19	PRICE SENSITIVE	254.77KB	Share
AN1 Appendix 4D, Half Year Accounts and Strategy Update
21/02/19	PRICE SENSITIVE	2.1MB	Share
AN1 Significant New Findings Published on Midkine
07/02/19	PRICE SENSITIVE	268.65KB	Share
AN1 Appendix 4C and Notes to Appendix 4C
23/01/19	PRICE SENSITIVE	549.1KB	Share
AN1 Cellmid Expects Record Sales in Q2 FY2019
12/12/18	PRICE SENSITIVE	222.34KB	Share
AN1 Cellmid Appoints Exclusive New Zealand Distributor
19/11/18	PRICE SENSITIVE	223.09KB	Share
AN1 Change of Director's Interest Notice - Halasz
13/11/18		356.45KB	Share
AN1 Change of Director's Interest Notice - Eck
13/11/18		350.32KB	Share
AN1 Appendix 3B and Cleansing Notice
12/11/18		898.77KB	Share
AN1 Results of Annual General Meeting
08/11/18		408.92KB	Share
AN1 AGM Presentation to Shareholders
08/11/18		1.85MB	Share
AN1 New Patents for Midkine Antibodies in USA and Europe
07/11/18	PRICE SENSITIVE	226.65KB	Share
AN1 Ikon Legal Action - Decision
02/11/18	PRICE SENSITIVE	199.86KB	Share
AN1 Trading Halt
02/11/18	PRICE SENSITIVE	144.58KB	Share
AN1 Cellmid's Evolis Successfully Launched in USA stores
01/11/18	PRICE SENSITIVE	227.68KB	Share
AN1 Repayment of R&D Loan
01/11/18	PRICE SENSITIVE	206.24KB	Share
AN1 Investor Presentation
31/10/18	PRICE SENSITIVE	2.36MB	Share
AN1 Cellmid receives R&D tax credit
30/10/18		62.71KB	Share
AN1 Appendix 4C and Notes to Appendix 4C
15/10/18	PRICE SENSITIVE	479.22KB	Share
AN1 Notice of Annual General Meeting/Proxy Form
09/10/18		1.25MB	Share
AN1 Appendix 3B and Cleansing Notice
08/10/18		887.46KB	Share
AN1 Cleansing Notice
03/10/18		196.69KB	Share
AN1 Appendix 3B
03/10/18		860KB	Share
AN1 Appendix 3B
28/09/18		875.43KB	Share
AN1 Change of Registry Address: Automic P/L - Sydney Office
28/09/18		91.41KB	Share
AN1 Appendix 4G and Corporate Governance Statement
27/09/18		525.71KB	Share
AN1 Annual Report to shareholders
27/09/18		2.27MB	Share
AN1 Change of Director's Interest Notice - Gordon
25/09/18		253.85KB	Share
AN1 Clarification Announcement
24/09/18		80.29KB	Share
AN1 CDY Investor Newsletter - 21 September 2018
21/09/18		526.81KB	Share
AN1 Date of Annual General Meeting
19/09/18		68.96KB	Share
AN1 Full Year Statutory Accounts
19/09/18		423.06KB	Share
AN1 Becoming a substantial holder
14/09/18		185.59KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.5¢		Change 0.000(0.00%)		Mkt cap ! $2.481M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
3	1596000	0.5¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	207362	1

View Market Depth

No.	Vol.	Price($)
3	1596000	0.005
7	7865199	0.004
3	5450000	0.003
2	2800000	0.002
3	2600000	0.001

Price($)	Vol.	No.
0.006	207362	1
0.007	125000	1
0.008	1323713	4
0.009	620000	2
0.010	500000	1

Last trade - 16.21pm 31/07/2025 (20 minute delay)

AN1 (ASX) Chart

Day chart unavailable

ANAGENICS LIMITED - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

A new NASDAQ listing for a key player in the global critical minerals space

Top Stories

ANAGENICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

A new NASDAQ listing for a key player in the global critical minerals space

Top Stories

Corporate Spotlight
Not Yet Available